| Institution: | 1. Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy;2. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy;3. Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy;4. Heart Center, Zürich University Hospital, University of Zürich, Zürich, Switzerland;5. Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands;6. Cardiologia, Centro Alte Specialità e Trapianti, Policlinico Vittorio Emanuele, Università di Catania, Catania, Italy;7. Department of Cardiology and Cardiac Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany;8. Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy;9. Civil Hospital and University of Brescia, Brescia, Italy;10. Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal;11. GVM Care and Research, Maria Cecilia Hospital, Ravenna, Italy;12. Division of Cardiology, Montefiore Medical Center, Bronx, New York |
| Abstract: | ObjectivesThe aim of this study was to evaluate and compare the outcomes of transcatheter self-expandable prostheses in patients with small annuli.BackgroundTranscatheter aortic heart valves appear to have better performance than surgical valves in terms of prosthesis-patient mismatch, especially in patients with aortic stenosis with small aortic annuli.MethodsTAVI-SMALL (International Multicenter Registry to Evaluate the Performance of Self-Expandable Valves in Small Aortic Annuli) is a retrospective registry of patients with severe aortic stenosis and small annuli (annular perimeter <72 mm or area <400 mm2 on computed tomography) treated with transcatheter self-expandable valves (n = 859; Evolut R, n = 397; Evolut PRO, n = 84; ACURATE, n = 201; Portico, n = 177). Primary endpoints were post-procedural mean aortic gradient, indexed effective orifice area, and rate of severe prosthesis-patient mismatch.ResultsPre-discharge gradients were consistently low in every group, with a slight benefit with the Evolut R (8.1 mm Hg; 95% confidence interval CI]: 7.7 to 8.5 mm Hg) and Evolut PRO (6.9 mm Hg; 95% CI: 6.3 to 7.6 mm Hg) compared with the ACURATE (9.6 mm Hg; 95% CI: 8.9 to 10.2 mm Hg) and Portico (8.9 mm Hg; 95% CI: 8.2 to 9.6 mm Hg) groups (p < 0.001). Mean indexed effective orifice area was 1.04 cm2/m2 (95% CI: 1.01 to 1.08 cm2/m2) with a trend toward lower values with the Portico. No significant differences were reported in terms of severe prosthesis-patient mismatch (overall rate 9.4%; p = 0.134), permanent pacemaker implantation (15.6%), and periprocedural and 1-year adverse events. Pre-discharge more than mild paravalvular leaks were significantly more common with the Portico (19.2%) and less common with the Evolut PRO (3.6%) compared with the Evolut R (11.8%) and ACURATE (9%) groups.ConclusionsTranscatheter self-expandable valves showed optimal clinical and echocardiographic results in patients with small aortic annuli, although supra-annular functioning transcatheter heart valves seemed to slightly outperform intra-annular functioning ones. The role of transcatheter aortic valve replacement with self-expandable valves for the treatment of aortic stenosis in patients with small annuli needs to be confirmed in larger trials. |
